These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 8718562)

  • 1. Retention of cytokine-inducing substances inside high-flux dialyzers.
    Lufft V; Mahiout A; Shaldon S; Koch KM; Schindler R
    Blood Purif; 1996; 14(1):26-34. PubMed ID: 8718562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood.
    Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA
    Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas aeruginosa contaminated dialysate.
    Jaber BL; Gonski JA; Cendoroglo M; Balakrishnan VS; Razeghi P; Dinarello CA; Pereira BJ
    Blood Purif; 1998; 16(4):210-9. PubMed ID: 9736790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers.
    Sundaram S; Barrett TW; Meyer KB; Perrella C; Neto MC; King AJ; Pereira BJ
    J Am Soc Nephrol; 1996 Oct; 7(10):2183-91. PubMed ID: 8915979
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine production during in vitro hemodialysis with new and formaldehyde- or renalin-reprocessed cellulose dialyzers.
    Pereira BJ; Snodgrass B; Barber G; Perella C; Chopra S; King AJ
    J Am Soc Nephrol; 1995 Oct; 6(4):1304-8. PubMed ID: 8589302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrogen retention by the Asahi APS-650 polysulfone dialyzer during in vitro dialysis with whole human donor blood.
    Linnenweber S; Lonnemann G
    ASAIO J; 2000; 46(4):444-7. PubMed ID: 10926143
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood.
    Schindler R; Krautzig S; Lufft V; Lonnemann G; Mahiout A; Marra MN; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1996 Jan; 11(1):101-8. PubMed ID: 8649615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis.
    Lonnemann G; Sereni L; Lemke HD; Tetta C
    Artif Organs; 2001 Dec; 25(12):951-60. PubMed ID: 11843762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffusive and convective transfer of cytokine-inducing bacterial products across hemodialysis membranes.
    Pereira BJ; Snodgrass BR; Hogan PJ; King AJ
    Kidney Int; 1995 Feb; 47(2):603-10. PubMed ID: 7723247
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in the permeability of high-flux dialyzer membranes for bacterial pyrogens.
    Schindler R; Christ-Kohlrausch F; Frei U; Shaldon S
    Clin Nephrol; 2003 Jun; 59(6):447-54. PubMed ID: 12834177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blood components influence cytokine induction by bacterial substances.
    Schindler R; Eichert F; Lepenies J; Frei U
    Blood Purif; 2001; 19(4):380-7. PubMed ID: 11574734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Kidney Foundation report on dialyzer reuse. Task Force on Reuse of Dialyzers, Council on Dialysis, National Kidney Foundation.
    Am J Kidney Dis; 1997 Dec; 30(6):859-71. PubMed ID: 9398135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria.
    Lonnemann G; Behme TC; Lenzner B; Floege J; Schulze M; Colton CK; Koch KM; Shaldon S
    Kidney Int; 1992 Jul; 42(1):61-8. PubMed ID: 1635355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes.
    Lonnemann G; Schindler R; Lufft V; Mahiout A; Shaldon S; Koch KM
    Nephrol Dial Transplant; 1995; 10(2):207-11. PubMed ID: 7753454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reprocessed (high-flux) Polyflux dialyzers resist trans-membrane endotoxin passage and attenuate inflammatory markers.
    Teehan GS; Guo D; Perianayagam MC; Balakrishnan VS; Pereira BJ; Jaber BL
    Blood Purif; 2004; 22(4):329-37. PubMed ID: 15240988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do cytokine-inducing substances penetrate through dialysis membranes and stimulate monocytes?
    Kumano K; Yokota S; Nanbu M; Sakai T
    Kidney Int Suppl; 1993 Jun; 41():S205-8. PubMed ID: 8320922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased binding of beta-2-microglobulin to blood cells in dialysis patients treated with high-flux dialyzers compared with low-flux membranes contributed to reduced beta-2-microglobulin concentrations. Results of a cross-over study.
    Traut M; Haufe CC; Eismann U; Deppisch RM; Stein G; Wolf G
    Blood Purif; 2007; 25(5-6):432-40. PubMed ID: 17957097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrafiltration and endotoxin removal from dialysis fluids.
    Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E
    Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dialyzer reuse--part II: advantages and disadvantages.
    Twardowski ZJ
    Semin Dial; 2006; 19(3):217-26. PubMed ID: 16689973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of peptidoglycan and endotoxin in dialysate, using silkworm larvae plasma and limulus amebocyte lysate methods.
    Tsuchida K; Takemoto Y; Yamagami S; Edney H; Niwa M; Tsuchiya M; Kishimoto T; Shaldon S
    Nephron; 1997; 75(4):438-43. PubMed ID: 9127331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.